Cidara Therapeutics, Inc.
CDTX
$22.15
-$0.21-0.94%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 189.83M | 127.39M | 164.37M | 29.02M | 35.78M |
| Total Receivables | 1.69M | 1.70M | 2.35M | 7.28M | 14.08M |
| Inventory | -- | -- | -- | 7.27M | -- |
| Prepaid Expenses | 12.87M | 27.69M | 1.87M | 3.27M | 1.71M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.35M | -- | -- | -- | 9.29M |
| Total Current Assets | 210.74M | 156.77M | 168.59M | 46.83M | 60.86M |
|
|
|||||
| Total Current Assets | 210.74M | 156.77M | 168.59M | 46.83M | 60.86M |
| Net Property, Plant & Equipment | 3.96M | 4.32M | 4.67M | 4.90M | 5.13M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 96.00K | 1.24M | 104.00K | 987.00K | 1.05M |
| Total Assets | 214.80M | 162.33M | 173.36M | 52.72M | 67.03M |
|
|
|||||
| Total Accounts Payable | 3.61M | 2.97M | 2.29M | 5.06M | 3.77M |
| Total Accrued Expenses | 44.30M | 39.79M | 35.82M | 34.58M | 37.25M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.64M | 1.58M | 1.52M | 1.46M | 1.30M |
| Total Finance Division Other Current Liabilities | -- | -- | 11.00K | 24.32M | 25.10M |
| Total Other Current Liabilities | -- | -- | 11.00K | 24.32M | 25.10M |
| Total Current Liabilities | 49.55M | 44.34M | 39.64M | 65.43M | 67.42M |
|
|
|||||
| Total Current Liabilities | 49.55M | 44.34M | 39.64M | 65.43M | 67.42M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.93M | 2.36M | 2.78M | 3.18M | 3.58M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 1.89M | 4.25M |
| Total Liabilities | 51.49M | 46.70M | 42.42M | 70.50M | 75.24M |
|
|
|||||
| Common Stock & APIC | 774.57M | 674.58M | 673.90M | 433.98M | 433.22M |
| Retained Earnings | -611.26M | -558.95M | -542.97M | -451.76M | -441.43M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 163.31M | 115.63M | 130.94M | -17.78M | -8.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 163.31M | 115.63M | 130.94M | -17.78M | -8.21M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 163.31M | 115.63M | 130.94M | -17.78M | -8.21M |
|
|
|||||
